CYCC - Why Cyclacel Pharmaceuticals (CYCC) Shares Are Getting Obliterated | Benzinga
Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) shares are trading lower by 26.9% to $2.63 Friday morning after the company announced it finalized an agreement to sell 388,200 shares of its common stock at $3.315 per share in a registered direct offering on Nasdaq.
Additionally, they'll issue warrants to purchase 388,200 shares ...
CYCC) Shares Are Getting Obliterated>Full story available on Benzinga.com